🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the producers of Tylenol, alleging the companies hid alleged dangers that the medication created to pediatric brain development.

The court filing arrives a month after President Donald Trump promoted an unverified association between using acetaminophen - alternatively called paracetamol - during pregnancy and autism in children.

The attorney general is suing the pharmaceutical giant, which previously sold the medication, the sole analgesic suggested for pregnant women, and Kenvue, which currently produces it.

In a official comment, he stated they "misled consumers by profiting off of pain and marketing drugs without regard for the dangers."

The manufacturer says there is insufficient reliable data tying Tylenol to autism spectrum disorder.

"These corporations misled for generations, deliberately risking millions to increase profits," Paxton, a Republican, declared.

Kenvue commented that it was "deeply concerned by the perpetuation of misinformation on the security of acetaminophen and the likely effects that could have on the well-being of women and children in America."

On its official site, Kenvue also mentioned it had "regularly reviewed the applicable studies and there is insufficient valid information that indicates a proven link between taking acetaminophen and autism."

Groups representing doctors and medical practitioners agree.

ACOG has stated paracetamol - the key substance in acetaminophen - is a restricted selection for pregnant women to address pain and fever, which can create major wellness concerns if ignored.

"In multiple decades of research on the utilization of acetaminophen in gestation, not a single reputable study has conclusively proven that the usage of acetaminophen in any trimester of pregnancy results in neurological conditions in young ones," the organization commented.

The court filing mentions latest statements from the former administration in arguing the medication is potentially dangerous.

Recently, the former president caused concern from public health officials when he instructed expectant mothers to "resist strongly" not to use Tylenol when ill.

The US Food and Drug Administration then published an announcement that medical professionals should think about restricting the use of acetaminophen, while also mentioning that "a causal relationship" between the medication and autism in minors has remains unverified.

Health Secretary Robert F Kennedy Jr, who oversees the Food and Drug Administration, had vowed in spring to conduct "extensive scientific investigation" that would identify the origin of autism spectrum disorder in a matter of months.

But experts warned that identifying a unique factor of autism - believed by scientists to be the result of a intricate combination of inherited and environmental factors - would prove challenging.

Autism spectrum disorder is a form of lifelong neurodivergence and disability that influences how persons encounter and engage with the environment, and is recognized using physician assessments.

In his court filing, the attorney general - a Trump ally who is campaigning for US Senate - claims Kenvue and Johnson & Johnson "willfully ignored and attempted to silence the research" around paracetamol and autism.

The lawsuit seeks to make the firms "destroy any commercial messaging" that asserts Tylenol is secure for pregnant women.

This legal action mirrors the concerns of a collection of guardians of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who sued the producers of acetaminophen in two years ago.

Judicial authorities rejected the legal action, declaring research from the parents' expert witnesses was not conclusive.